Medicine and Dentistry
Acute Kidney Injury
100%
Nephrotic Syndrome
63%
Chronic Kidney Disease
52%
Glomerulopathy
49%
Neonate
48%
Focal Segmental Glomerulosclerosis
37%
Nephropathy
36%
Prematurity
34%
Acute Renal Failure
29%
Apolipoprotein L1
28%
Disease
28%
Injury Epidemiology
24%
Pediatrics
22%
Neonatal Intensive Care Unit
22%
Kidney Function
21%
COVID-19
20%
Adolescent
20%
Drug Therapy
19%
Blood Pressure
19%
Glomerular Filtration Rate
19%
Gestational Age
16%
Creatinine
16%
Disease Activity
16%
Cohort Effect
15%
Low Birth Weight
14%
Podocyte
13%
End Stage Renal Disease
13%
Premature Labor
13%
Fluid Balance
12%
Kidney Development
12%
Observational Study
12%
Minimal Change Disease
12%
Health Outcomes
12%
Patent Ductus Arteriosus
12%
Progenitor Cell
11%
Pediatric Nephrology
11%
Pre-Eclampsia
11%
Acidosis
11%
Sodium Bicarbonate
11%
Proteinuria
10%
Metabolic Acidosis
10%
Injury
10%
Artificial Respiration
9%
Prevalence
9%
Biopsy
9%
Patient-Reported Outcome
9%
Allele
9%
Disease Course
9%
Urinary System
9%
Medication Compliance
9%
Keyphrases
Nephrotic Syndrome
31%
Apolipoprotein L1 (APOL1)
29%
Acute Kidney Injury
23%
Neonatal Acute Kidney Injury
17%
Blood Pressure
17%
Focal Segmental Glomerulosclerosis
15%
COVID-19
15%
AKI Epidemiology
14%
Neonate
13%
Kidney Disease
13%
Steroid-resistant Nephrotic Syndrome
13%
High Risk
12%
Podocyte
12%
Chronic Kidney Disease in children
11%
Overexpression
11%
Dysnatremia
11%
Prematurity
11%
High-risk HPV
10%
Glomerular Disease
9%
African Ancestry
9%
Hemoglobin
8%
Rapid Progression
8%
Hypertensive
7%
Nephropathy
7%
Medication Exposure
7%
Late Acute
7%
Gestational Age
7%
Vascular Endothelial Growth Factor
7%
Preterm Birth
7%
Nephrotoxic Medications
7%
Kidney Disease Progression
6%
Genotype
6%
Risk Variant
6%
Older Adults
6%
Sickle Cell Disease
6%
Dyslipidemia
6%
Renal Tubule
5%
Heat Shock Factor
5%
Research Mentorship
5%
Neonatal Hypertension
5%
African American children
5%
African American Population
5%
IgA Vasculitis (IgAV)
5%
Glomerulonephropathy
5%
Child Growth
5%
Hypernatremia
5%
Preterm Neonates
5%
CKD Risk
5%
Early Life Course
5%
Early-life Socioeconomic Status
5%